JB Chemicals & Pharmaceuticals Ltd Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 4,968.65 | 4,273.78 | 3,994.13 | 3,553.87 |
| Accumulated Depreciation Total | -814.89 | -770.31 | -700.38 | -643.49 |
| Cash Equivalents | 2.88 | 36.00 | 23.50 | 26.91 |
| Other Liabilities Total | 32.95 | 24.43 | 20.09 | 17.70 |
| Common Stock Total | 16.06 | 15.57 | 15.52 | 15.48 |
| Other Equity Total | 27.53 | -1.90 | -14.87 | -3.97 |
| Other Current Assets Total | 7.99 | 4.35 | 3.40 | 3.21 |
| Prepaid Expenses | 17.46 | 19.01 | 16.32 | 16.70 |
| Total Assets | 4,968.65 | 4,273.78 | 3,994.13 | 3,553.87 |
| Current Portof LT Debt/ Capital Leases | 2.46 | 7.73 | 329.04 | 145.89 |
| Additional Paid- In Capital | 634.57 | 164.06 | 113.39 | 69.73 |
| Cash | 107.30 | 79.09 | 64.71 | 50.02 |
| Total Equity | 4,159.22 | 3,433.32 | 2,923.33 | 2,480.35 |
| Long Term Investments | 41.72 | 278.39 | 28.51 | 27.40 |
| Retained Earnings( Accumulated Deficit) | 3,480.72 | 3,255.24 | 2,808.94 | 2,398.76 |
| Total Common Shares Outstanding | 16.06 | 15.57 | 15.52 | 15.48 |
| Property/ Plant/ Equipment Total- Gross | 1,487.67 | 1,426.96 | 1,335.26 | 1,219.91 |
| Tangible Book Valueper Share Common Eq | 178.92 | 132.24 | 95.20 | 71.12 |
| Goodwill Net | 57.46 | 57.46 | 57.46 | 57.46 |
| Total Liabilities | 809.43 | 840.46 | 1,070.80 | 1,073.52 |
| Total Debt | 3.59 | 27.89 | 377.66 | 572.45 |
| Short Term Investments | 1,111.17 | 335.00 | 371.42 | 192.27 |
| Cashand Short Term Investments | 1,221.35 | 450.09 | 459.64 | 269.20 |
| Total Receivables Net | 968.17 | 901.55 | 860.19 | 794.84 |
| Notes Payable/ Short Term Debt | 0.00 | 13.80 | 15.34 | 28.02 |
| Deferred Income Tax | 184.18 | 177.34 | 149.21 | 102.82 |
| Accounts Receivable- Trade Net | 805.70 | 816.44 | 687.43 | 576.19 |
| Property/ Plant/ Equipment Total- Net | 672.78 | 656.64 | 634.88 | 576.42 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 591.16 | 632.34 | 868.23 | 554.45 |
| Total Inventory | 694.40 | 547.73 | 513.79 | 444.08 |
| Accounts Payable | 390.98 | 410.72 | 356.31 | 238.65 |
| Other Currentliabilities Total | 197.72 | 200.09 | 167.54 | 141.87 |
| Total Long Term Debt | 1.12 | 6.35 | 33.28 | 398.54 |
| Intangibles Net | 1,229.10 | 1,317.14 | 1,388.45 | 1,322.28 |
| Other Long Term Assets Total | 8.98 | 14.39 | 12.28 | 12.38 |
| Note Receivable- Long Term | 49.23 | 27.01 | 19.20 | 29.89 |
| Unrealized Gain( Loss) | 0.35 | 0.35 | 0.35 | 0.35 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 2,909.37 | 1,922.74 | 1,853.35 | 1,528.03 |
| Capital Lease Obligations | 1.12 | 6.35 | 9.64 | 15.32 |
| Long Term Debt | - | 0.00 | 23.64 | 383.22 |
| Accrued Expenses | - | - | 0.00 | 0.03 |
JB Chemicals & Pharmaceuticals Ltd Quick Links
JB Chemicals & Pharmaceuticals Ltd Dividend JB Chemicals & Pharmaceuticals Ltd Bonus JB Chemicals & Pharmaceuticals Ltd News JB Chemicals & Pharmaceuticals Ltd AGM JB Chemicals & Pharmaceuticals Ltd Rights JB Chemicals & Pharmaceuticals Ltd Splits JB Chemicals & Pharmaceuticals Ltd Board Meetings JB Chemicals & Pharmaceuticals Ltd Key Metrics JB Chemicals & Pharmaceuticals Ltd Shareholdings JB Chemicals & Pharmaceuticals Ltd Profit Loss JB Chemicals & Pharmaceuticals Ltd Cashflow JB Chemicals & Pharmaceuticals Ltd Q1 Results JB Chemicals & Pharmaceuticals Ltd Q2 Results JB Chemicals & Pharmaceuticals Ltd Q3 Results JB Chemicals & Pharmaceuticals Ltd Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.